Product Information
CEFEPIME HCL 2 GRAM VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $5.3480 per EA under NDC 25021012250. Its NADAC has been published 122 times since Jan 22, 2014.
Strength
2 g/1
Manufacturer
Sagent PharmaceuticalsNDC
25021012250
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
3/19/2025
Active Ingredients
CEFEPIME HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065441On Market Since
5/1/2008
Pharmacological Classes
Price Statistics
The NADAC for CEFEPIME HCL 2 GRAM VIAL has been published 122 times since Jan 22, 2014, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3480 per EA |
|---|---|
| All-time high | $7.9605 (Dec 16, 2015) |
| All-time low | $5.3480 (Mar 19, 2025) |
| Median price | $7.9065 |
| Average price | $7.4932 |
| Largest weekly change | -30.1% (Nov 20, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the cefepime hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CEFEPIME HCL 2 GRAM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFEPIME HCL 2 GRAM VIAL, manufactured by Sagent Pharmaceuticals, is $5.3480 per EA (NDC 25021012250), effective Apr 16, 2025.
How has the price of CEFEPIME HCL 2 GRAM VIAL changed over time?
Over the history we have for it, the NADAC for CEFEPIME HCL 2 GRAM VIAL has declined 32.4%. It has been tracked across 122 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CEFEPIME HCL 2 GRAM VIAL?
Since Jan 22, 2014, the NADAC for CEFEPIME HCL 2 GRAM VIAL has ranged from a low of $5.3480 (Mar 19, 2025) to a high of $7.9605 (Dec 16, 2015), with a median of $7.9065 per EA.
Are there cheaper alternatives to CEFEPIME HCL 2 GRAM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CEFEPIME HCL 2 GRAM VIAL, so no direct lower-cost alternative is listed.
Who manufactures CEFEPIME HCL 2 GRAM VIAL?
CEFEPIME HCL 2 GRAM VIAL (NDC 25021012250) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification